MYMD Cash Flow Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
Report Filing: 2024-05-15 2024-04-01 2023-11-14 2023-08-14 2023-05-15 2023-03-31
1234
Net Income/Starting Line -9800041 -2363559 4042994 -4167653 -1511732 -3745518
1234
Cash From Operating Activities -1912041 -1932630 -3156478 -3919875 -3971642 -2248404
1234
Depreciation and Amortization 0 0 0 0 0 0
1234
Deferred Income Tax 0 0 0 0 0 0
1234
Stock Based Compensation 0 1619844 385143 1024642 19908 45222
1234
Other Non-Cash Items 7406075 -3341337 -7714291 -786499 -1003603 68216
1234
Changes in Working Capital 336911 2152422 129676 9635 -1476215 1383676
1234
Accounts Receivable 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0
1234
Accounts Payable 145014 1682378 -122612 787252 -1304021 955912
1234
Deferred Revenue 191897 470044 252288 -777617 -172194 427764
1234
Other Working Capital 0 0 0 0 0 0
1234
Cash From Investing Activities 732024 5934192 3360973 3825150 -11274589 2687568
1234
Investments in Property Plant and Equipment 0 0 0 0 0 0
1234
Payments for Acquisitions 0 0 0 0 0 0
1234
Purchases of Securities -18306 -115838 -139057 -174850 -13024559 -62432
1234
Proceeds from Sales and Maturities of Securities 750330 6050030 3500030 4000000 1749970 2750000
1234
Other Investing Activities 0 5934.192 3360.973 3825.1499999999996 -11274.589 2687.568
1234
Cash From Financing Activities -1275338 -1618870 6 -174851 14685689 0
1234
Debt Repayment 0 -168 -6 -5 -157 0
1234
Common Stock Issued 0 -29196522 0 14510833 14685689 5550028
1234
Common Stock Repurchased -73472 -89635 0 -14685689 -157 0
1234
Dividends Paid -1133762 0 0 0 0 0
1234
Other Financing Activities -68104 -77090 12 174861 158647 -5550028
1234
Effect of Forex Changes on Cash 0 -174845 -6 174851 0 0
1234
Net Change in Cash -2455355 2382692 204495 -94725 -560542 439164
1234
Cash at Beginning of Period 2681010 298318 93823 188548 749090 309926
1234
Cash at End of Period 225655 2681010 298318 93823 188548 749090
1234
Free Cash Flow -1912041 -1932630 -3156478 -3919875 -3971642 -2248404
1234
Operating Cash Flow -1912041 -1932630 -3156478 -3919875 -3971642 -2248404
1234
Capital Expenditure 0 0 0 0 0 0
1234

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.